0001171843-23-000853.txt : 20230209
0001171843-23-000853.hdr.sgml : 20230209
20230209162825
ACCESSION NUMBER: 0001171843-23-000853
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230208
FILED AS OF DATE: 20230209
DATE AS OF CHANGE: 20230209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferneau Philip
CENTRAL INDEX KEY: 0001814202
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39696
FILM NUMBER: 23606630
MAIL ADDRESS:
STREET 1: 10 ALLEN STREET
CITY: HANOVER
STATE: NH
ZIP: 03755
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Compass Therapeutics, Inc.
CENTRAL INDEX KEY: 0001738021
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-500-8099
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Olivia Ventures, Inc.
DATE OF NAME CHANGE: 20180419
4
1
ownership.xml
X0306
4
2023-02-08
0
0001738021
Compass Therapeutics, Inc.
CMPX
0001814202
Ferneau Philip
C/O COMPASS THERAPEUTICS, INC.
80 GUEST STREET, SUITE 601
BOSTON
MA
02135
1
0
0
0
Stock Option (Right to Buy)
3.93
2023-02-08
4
A
0
50000
0
A
2033-02-07
Common Stock
50000
50000
D
The options vest over 48 substantially equal monthly installments starting March 8, 2023.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
/s/ Neil Lerner, attorney-in-fact
2023-02-09